Navigate to
-
Live updates from AMCP Annual Meeting
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
ensitrelvir - Infectious disease Name Manufacturer Clinical use Dosage form Development status - FDA designations FDA decision oxylanthanum carbonate (Renazorb) Unicycive Hyperphosphatemia (in...
-
-
Table view Editor-in-chief's message Year 2024 2025 2026 2027 2028 Projected Yearly U.S. Sales $0 $82 $177 $258 $311 The pipeline drug list is an aerial outline of drugs with anticipated FDA...
-
Name Manufacturer Clinical use Dosage form Development status - FDA designations FDA decision aflibercept (Eylea HD) 8 mg Regeneron Macular edema from RVO (8 mg dose) Intravitreal sNDA – PR Oct-Dec...
-
Jessica Johnson, clinical consultant, shares how the Special Investigations Unit at Prime helps identify cases of fraud
PA Sub-Categories: GLP-1 Prime Article: Perspectives -
Real-world, integrated data follows-up on previous insights, analytics.
PA Sub-Categories: GLP-1 Prime Article: Press Releases -